Category: Delcath Systems Inc.Syndicate content

Delcath expands Phase II trial

December 19, 2014 by Val Kennedy

Delcath Systems adds 2 German research centers to a Phase II clinical trial of its Chemosat melphalan hepatic delivery system in treating primary liver cancer.

Delcath expands Phase II trial

Delcath Systems (NSDQ:DCTH) said it added 2 German research centers to a global Phase II trial of its Chemosat melphalan hepatic delivery system in treating primary liver cancer.

Delcath Systems tanks following reverse stock split

April 9, 2014 by Arezu Sarvestani

Wall Street flees from troubled Delcath Systems after the cancer-treatment devices maker proceeds with a 1-to-16 reverse stock split.

Delcath Systems tanks following news of reverse stock split

Shares of Delcath (NSDQ:DCTH) dropped more than 18% by the early afternoon today after the company proceeded with a 1-to-16 reverse stock split.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech personnel moves for the week of Mar. 10, 2014

March 11, 2014 by MassDevice staff

Here's a look at some of the top personnel stories for medical device companies this week.

ConMed proxy war gets ugly

February 28, 2014 by Brad Perriello

ConMed proxy war gets ugly

The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company's nominees for director.

Medtronic vet takes over marketing at Vexim | Personnel Moves

March 5, 2014 by Arezu Sarvestani

Spinal devices maker Vexim appoints as its director of marketing Sandrine Carle, a veteran of spinal operations at medtech giant Medtronic.

fired/hired

French spinal devices maker Vexim (EPA:ALVXM) this month welcome Medtronic (NYSE:MDT) veteran Sandrine Carle as its director of marketing.

Neuro Kinetics appoints new CFO | Personnel Moves

December 24, 2013 by Chris Walker

Neuro Kinetics named former Zoll Medical executive Michael Saporito as CFO.

fired/hired

Neuro Kinetics appointed Michael Saporito as its new CFO.

Saporito joins the Pittsburgh-based medical device company after years with LifeVest, which he helped turn around before the company was bought out by Zoll Medical.

Troubled Delcath announces $7.5M offering, drops 23%

October 23, 2013 by Arezu Sarvestani

Amid a flurry of layoffs and restructuring after failed attempts to win FDA approval, New York device maker Delcath Systems aims for a $7.5 million funding round.

Troubled Delcath aims for $7.5M offering

New York's Delcath Systems (NSDQ:DCTH) is looking to raise about $7.5 million through sales of common stock, planning on using the funds for working capital, commercialization efforts, clinical trials and other "general corporate purposes."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp